PerOs Systems Technologies Inc. is a privately held biotechnology company that has developed efficient non-encapsulation strategies that allow bioactive compounds to be delivered orally. The company was established in Canada in early 2000 after a revolutionary discovery that permits the oral delivery of a variety of therapeutic molecules, including vaccines, peptides and nutraceuticals. PerOs' patented Oralject™ technology is used for delivering large molecules.